Laboratorios Farmaceuticos Rovi Dividends and Buybacks
Dividend criteria checks 4/6
Laboratorios Farmaceuticos Rovi is a dividend paying company with a current yield of 1.77% that is well covered by earnings.
Key information
1.8%
Dividend yield
3.5%
Buyback Yield
| Total Shareholder Yield | 5.3% |
| Future Dividend Yield | 2.4% |
| Dividend Growth | 4.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €1.104 |
| Payout ratio | 39% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 41L's dividend payments have been volatile in the past 10 years.
Growing Dividend: 41L's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Laboratorios Farmaceuticos Rovi Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (41L) | 1.8% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (41L) (up to 3 years) | 2.4% |
Notable Dividend: 41L's dividend (1.77%) is higher than the bottom 25% of dividend payers in the German market (1.67%).
High Dividend: 41L's dividend (1.77%) is low compared to the top 25% of dividend payers in the German market (4.86%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (38.9%), 41L's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (88.3%), 41L's dividend payments are covered by cash flows.